These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quality Risk Management Competency Model-Case for the Need for QRM Competencies. Haddad G; Greene A PDA J Pharm Sci Technol; 2019; 73(4):331-344. PubMed ID: 31101709 [TBL] [Abstract][Full Text] [Related]
3. A practical discussion of risk management for manufacturing of pharmaceutical products. Mollah AH; Baseman HS; Long M; Rathore AS PDA J Pharm Sci Technol; 2014; 68(3):271-80. PubMed ID: 25188348 [TBL] [Abstract][Full Text] [Related]
4. Quality management benchmarking: FDA compliance in pharmaceutical industry. Jochem R; Landgraf K Int J Health Care Qual Assur; 2010; 23(8):690-8. PubMed ID: 21125964 [TBL] [Abstract][Full Text] [Related]
5. Enabling ICH Q10 Implementation--Part 1. Striving for Excellence by Embracing ICH Q8 and ICH Q9. Calnan N; O'Donnell K; Greene A PDA J Pharm Sci Technol; 2013; 67(6):581-600. PubMed ID: 24265300 [TBL] [Abstract][Full Text] [Related]
6. [Pharmaceutical product quality control and good manufacturing practices]. Hiyama Y Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):1-16. PubMed ID: 21381389 [TBL] [Abstract][Full Text] [Related]
7. A cross-industry forum on benchmarking critical quality attribute identification and linkage to process characterization studies. Demmon S; Bhargava S; Ciolek D; Halley J; Jaya N; Joubert MK; Koepf E; Smith P; Trexler-Schmidt M; Tsai P Biologicals; 2020 Sep; 67():9-20. PubMed ID: 32665104 [TBL] [Abstract][Full Text] [Related]
8. Proposal on How To Conduct a Biopharmaceutical Process Failure Mode and Effect Analysis (FMEA) as a Risk Assessment Tool. Zimmermann HF; Hentschel N PDA J Pharm Sci Technol; 2011; 65(5):506-12. PubMed ID: 22293839 [TBL] [Abstract][Full Text] [Related]
9. Use of benchmarking in the development of biopharmaceutical products. Giffin M; McLeish S Biotechnol Annu Rev; 2003; 9():279-84. PubMed ID: 14650932 [TBL] [Abstract][Full Text] [Related]
10. A risk-based approach to scheduling audits. Rönninger S; Holmes M PDA J Pharm Sci Technol; 2009; 63(6):575-88. PubMed ID: 20169864 [TBL] [Abstract][Full Text] [Related]
19. Managing the interface with marketing to improve delivery of pharmacovigilance within the pharmaceutical industry. Edwards B Drug Saf; 2004; 27(8):609-17. PubMed ID: 15154832 [TBL] [Abstract][Full Text] [Related]
20. Process analytical technology (PAT) for biopharmaceutical products. Rathore AS; Bhambure R; Ghare V Anal Bioanal Chem; 2010 Sep; 398(1):137-54. PubMed ID: 20480150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]